Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies
Citation Manager Formats
Make Comment
See Comments
See original article:

Article Information
- Received October 5, 2020
- Accepted in final form November 12, 2021
- First Published February 23, 2021.
Author Disclosures
- Su-Hyun Kim, MD, PhD (herena20{at}ncc.re.kr),
- Hyunmin Jang, RN,
- Na Young Park, RN,
- Yeseul Kim, MSc,
- So-Yeon Kim, BSc,
- Min Young Lee, MD (74687{at}ncc.re.kr),
- Jae-Won Hyun, MD, PhD (jacksy12{at}naver.com) and
- Ho Jin Kim, MD, PhD
- Su-Hyun Kim, MD, PhD (herena20{at}ncc.re.kr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Bio & Medical Technology Development Program (M3A9B6069339) (2) National Research Foundation of Korea (Grant No. NRF- 2016R1D1A1A09916480)
NONE
NONE
NONE
NONE
NONE
NONE
- Hyunmin Jang, RN,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Na Young Park, RN,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yeseul Kim, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- So-Yeon Kim, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Min Young Lee, MD (74687{at}ncc.re.kr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jae-Won Hyun, MD, PhD (jacksy12{at}naver.com) and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) National Research Foundation of Korea, NRF- 2020R1F1A1072174, principal investigator, 2020
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ho Jin Kim, MD, PhD
NONE
NONE
Received travel expenses and/or honoraria for lectures or educational activities from Alexion, Biogen, Celltrion, Eisai, Merck Serono, Novartis, Sanofi Genzyme, Teva-Handok, and Viela Bio
Multiple Sclerosis Journal, Coeditor, 2019 Journal of Clinical Neurology, Associate Editor, 2016
NONE
NONE
NONE
Aprilbio, HanAll BioPharma, MDimune, Merck Serono, Sanofi Genzyme, and Viela Bio
NONE
NONE
NONE
NONE
National Research Foundation of Korea, 2018R1A5A2023127, , Co-Principal Investigator, 2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, South Korea.
- Correspondence
Dr. Kim hojinkim{at}ncc.re.kr
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps et al.Neurology, March 13, 2020 -
Article
Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica DisorderNicolas Collongues, Cecilia Alves Do Rego, Bertrand Bourre et al.Neurology, February 24, 2021 -
Article
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorderMargherita Nosadini, Gulay Alper, Catherine J. Riney et al.Neurology - Neuroimmunology Neuroinflammation, January 21, 2016 -
Article
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated DiseasesAlexandre Avouac, Adil Maarouf, Jan-Patrick Stellmann et al.Neurology: Neuroimmunology & Neuroinflammation, March 15, 2021